Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

MK-677 Air Bubbles vs Dose Accuracy: Comparison

Embolism Risk (Subcutaneous) None. Volume 4,000× below IV threshold None. Volume 1,000× below IV threshold None. No air present Air embolism from subcutaneous peptide injection is physiologically implausible at syringe volumes Dose Accuracy (1 mL Syringe) 5% d

This comparison does not assign a generated winner or score.

  • Embolism Risk (Subcutaneous)
  • None. Volume 4,000× below IV threshold
  • None. Volume 1,000× below IV threshold
  • None. No air present
  • Air embolism from subcutaneous peptide injection is physiologically implausible at syringe volumes
  • Dose Accuracy (1 mL Syringe)
  • 5% dose reduction
  • 20% dose reduction
  • 100% accurate
  • Dose variability is the actual measurable consequence, not safety risk
  • IGF-1 Response Impact
  • Minimal. Within biological variability
  • Significant. May blunt GH pulse amplitude
  • Maximised. Dose delivered as intended
  • Chronic underdosing from air displacement compounds over weeks, degrading protocol consistency
  • Time to Clear Air
  • 15–20 seconds with flick-and-tap method
  • 30–40 seconds. May require re-draw if excessive
  • N/A. Already clear
  • Degassing takes seconds and eliminates the only real variable air introduces
  • User Anxiety Level
  • Moderate. Visible but small
  • High. 'should I re-draw entirely?'
  • Low. Technical confidence increases
  • Most air-related dosing errors occur because anxiety prompts users to re-draw or adjust mid-protocol
More references

Related material